Objective: To investigate stretch-induced electrophysiological changes in chronically infarcted hearts and the effect of streptomycin (SM) on these changes in vivo. Methods: Sixty Wistar rats were divided randomly into four groups: a control group (n=15), an SM group (n=15), a myocardial infarction (MI) group (n=15), and an MI+SM group (n=15). Chronic MI was obtained by ligating the left anterior descending branch (LAD) of rat hearts for eight weeks. The in vivo blockade of stretch-activated ion channels (SACs) was achieved by intramuscular injection of SM (180 mg/(kg·d)) for seven days after operation. The hearts were stretched for 5 s by occlusion of the aortic arch. Suction electrodes were placed on the anterior wall of left ventricle to record the monophasic action potential (MAP). The effect of stretching was examined by assessing the 90% monophasic action potential duration (MAPD 90 ), premature ventricular beats (PVBs), and ventricular tachycardia (VT 
Introduction
There is a close relationship between malignant ventricular arrhythmias and myocardial infarction (MI) (Haugaa et al., 2010) , which leads to high cardiovascular mortality (Wang, 2012) . It is well recognized that mechanical restitution and regional inhomogeneity in contractility act as foci for arrhythmias (Thygesen and Uretsky, 2004; Ashikaga et al., 2005) through a process known as mechanoelectric feedback (MEF). In chronic MI, scar tissue is surrounded by normal or ischemic myocardium, and greater stretch occurs than in normal myocardium (Bertini et al., 2010) . Previous studies also verified that MEF can be increased by chronic MI (Kiseleva et al., 2000) , contributing to the appearance of arrhythmias. We inferred that electrophysiological changes induced by stretch in normal hearts, shortened action potential duration (APD), the occurrence of after-depolarization, and premature beats (Kiseleva et al., 2000; Ravens, 2003; Taggart and Lab, 2008 ) might be observed in chronically infarcted myocardium. Many studies have demonstrated that stretch-activated ion channels (SACs) have a crucial role to perform in MEF, though details of the mechanism are unclear (Garan et al., 2005; Lab, 2006) . Streptomycin (SM), a blocker of SACs, has been known to inhibit the activities of SACs in single cell, tissue, and intact preparations in various species (Lab, 2006) . It can decrease the occurrence of arrhythmias induced by changes in ventricular wall-stress in isolated rat hearts (Salmon et al., 1997) . Eckardt et al. (2001) studied Langendorff-perfused rabbit hearts and found that SM (200 μmol/L) could inhibit the shortened repolarization induced by stretching. The dominant frequency of ventricular fibrillation (VF) induced by stretching decreases following SM treatment in rabbit hearts (Trapero et al., 2008) . SM also prevents stretch-related vulnerability to atrial fibrillation (Ninio and Saint, 2008) . In hearts from hypertensive rats, Kim et al. (2012) recently found that 100 μmol/L SM could reduce stretch-induced ectopic heartbeats by increasing the threshold for stretchinduced arrhythmias.
However, the effect of blocking of SACs with SM has seldom been observed in vivo, and results are often contradictory. Cooper and Kohl (2005) reported that SM could not block chronotropy in the spontaneous pacemaking rate induced by stretching, and further questioned the in situ utility of SM for acute blocking of mechanosensitive mechanisms. Garan et al. (2005) found that SM reduced ST segment elevation following impact in swine but did not reduce the frequency of VF. Using skeletal muscle, Yeung et al. (2005) and Spangenburg and McBride (2006) found that oral SM in vivo could block the activities of SACs in the rat and mouse, respectively. However, there has been no analogous study on myocardium.
The aim of this study was to observe the effect of stretching on the monophasic action potential (MAP) and the effect of the application of SM in vivo on electrophysiological changes in chronically infarcted rat hearts.
Materials and methods

Preparation of MI model
The study was performed in accordance with the rules of The Care and Use of Laboratory Animals issued by the US National Institute of Health (NIH Publication No. 85-23, revised in 1985) .
Sixty Wistar rats (regardless of their genders, 180-224 g) were chosen for the experiment. Each rat, anaesthetized by intraperitoneal injection using sodium pentobarbital (40-50 mg/kg) and heparin (1000 U/kg), was intubated and then connected to a respirator. Artificial respiration was provided during the whole surgical process (breathing rate 60 min −1 , tidal volume 30 ml/100 mg). Electrocardiograms (ECG; limb leads including I, II, III, aVR, aVL, aVF) were recorded from electrodes attached to the limbs of each rat. Briefly, MI was obtained by ligating the left anterior descending branch (LAD) of the coronary artery. First, the heart was exteriorized between the 3rd and 4th costal bones of the left sternal border. Second, the LAD was ligated between the pulmonary conus and the left auricle. Successful ligature of the LAD was verified by regional myocardial cyanosis and ST elevation in the ECG. Third, the heart was replaced and the cut was stitched. Sham-operated animals were operated following the procedure mentioned above, but without ligation of the LAD. The surviving rats were kept in a cage and fed with a full diet and water.
Sham-operated animals were divided at random into two groups: a control group (n=15) in which experiments were carried out after 8 weeks and an SM group (n=15) in which after 7 weeks, the rats were injected intramuscularly with SM (Merro Pharmaceuticals Companies; 180 mg/(kg·d)) for 7 d. Experiments were then conducted. MI animals were also divided into two groups: an MI group (n=15) in which experiments were carried out 8 weeks after ligature of the LAD and an MI+SM group (n=15) in which, after ligation of the LAD for 7 weeks, the rats were injected intramuscularly with SM (180 mg/(kg·d)) for 7 d. Experiments were then conducted.
Recording
Each animal was anaesthetized and ventilated as mentioned above. ECG was recorded during the whole experiment. The right common carotid artery was dissociated. A catheter was connected to a pressure transducer (YP500, Gaobeidian, China), which was inserted into the left ventricle (LV) via the right common carotid artery and aorta by catheterization to measure the pressure of the ventricle. The distance between the end of the catheter and the transducer was minimized to decrease system dampening. Thoracotomy was performed. The heart and aortic arch were revealed. A suction electrode, placed on the anterior wall of the LV, was used to detect LV MAP (Fu et al., 2007) .
Protocols
After stabilization for 15 min, the heart was stretched by an occlusion of the aortic arch for 5 s, followed by unclamping of the aortic arch. The 90% monophasic action potential duration (MAPD 90 ), LV pressure, premature ventricular beats (PVBs), and ventricular tachycardia (VT) were monitored during 5 s of stretching.
Data analysis
The measurement and analysis of MAPD 90 (in ms) were conducted according to the criteria of Fu et al. (2007) . Every five beats, one MAP was analyzed and then averages were calculated. Stretch-induced arrhythmias (SIAs) were defined according to the guidelines of the Lambeth Convention (Curtis et al., 2013) . Data were analyzed using SPSS 13.0 (Statistical Package for the Social Sciences 13.0, SPSS Company, USA) by an independent University-based statistician. Quantitative data, expressed as mean± standard deviation (SD), were compared with analysis of variance (ANOVA). A χ 2 test was used for qualitative data. P<0.05 was considered statistically significant.
Results
Effect of stretching on MAPD 90
During the occlusion of the aortic arch, the MAPD 90 decreased, compared with the basal condition in the control group ((50.27±5.61) (Fig. 1) .
Effect of SM on MAPD 90 changes during stretching
After the treatment with SM, the MAPD 90 showed no significant changes from basal conditions either in normal ((50.27±5.61) (Fig. 1) (Fig. 1) .
Effect of SM on SIAs
The PVBs appeared during the occlusion of the aorta. The number of PVBs was counted during the 5 s of occlusion of the aorta. The incidence of PVBs in the control group was observed during stretching (1.80±0.86). After ligation of the LAD for eight weeks, the incidence showed a marked and significant increase (7.93±1.66 in the MI group vs. (n=15) During the occlusion of the aortic arch for 5 s, the number of VT in the control group was 1, whereas it increased to 7 in the MI group. After treatment with SM, the number of VT decreased to 0 in the SM group and to 3 in the MI+SM group. The incidence of VT was higher than that in the control group (P<0.05). SM decreased the occurrence of VT, but there was no significant difference between incidence in the MI+ SM group and the MI group (P>0.05) ( Table 2) .
Discussion
The present study found that the application of SM in vivo could inhibit changes in MAPD 90 and decrease the incidence of PVBs induced by stretching of chronically infarcted rat hearts. However, SM did not reduce the occurrence of VT, indicating the involvement of SACs in the genesis of stretchinduced PVBs in chronic MI, but suggesting a more complicated situation for stretch-induced VT.
Changes in MAPD 90 and arrhythmias induced by stretching
Changes in MAPD caused by transiently increasing LV pressure have been reported in the normal myocardium of many species (Reiter et al., 1997; Takagi et al., 1999; Lerman et al., 2001) . Consistent with the results of earlier studies, the MAPD 90 of the LV was shortened during transient aortic occlusion in this study. Furthermore, we found that the stretchinduced decrease in MAPD 90 in vivo also had happened in the chronic MI rat hearts. By using a slice from the LV after MI treatment for five weeks, Kiseleva et al. (2000) found that the sensitivity of the The number of hearts with VT increased with stretching after ligation of the left anterior descending artery for eight weeks ( * P<0.05). SM decreased the occurrence of VT, but the difference was not significant (P>0.05) membrane potential and depolarization to stretch increased. Fu et al. (2007) verified that the phenomenon of MEF increased in acute myocardium infarction (AMI) as well. The contraction force of ischaemic and infarcted myocardium was lower than that of surrounding normal myocardium after MI. So, stretch exists between the normal and ischemic myocardia. Likewise, stretch also exists between the infarcted and ischemic myocardia in chronic MI. In the present study, more PVBs and VT occurred in infarcted myocardium with occlusion of the aorta, which is consistent with previous results (Horner et al., 1996) .
Effects of the application of SM in vivo on MAPD 90
In single cardiomyocytes (Belus and White, 2003) and multicellular preparations (Eckardt et al., 2000; Spangenburg and McBride, 2006) , SM has been verified to be an effective blocker of SACs. This study confirmed that the stretch-induced decrease in MAPD 90 in chronic MI could be pharmacologically inhibited by an SAC blocker. SM had no effect on the MAPD 90 under basic conditions, but effectively inhibited the shortening of the MAPD 90 induced by transient aortic occlusion in both normal and chronically infarcted hearts. Based on these results and the characteristics of MEF, we inferred that: (1) in chronic MI, the activities of SACs were involved in the stretch-induced changes in the MAPD 90 ; (2) treatment with SM in vivo can inhibit the activities of SACs.
Effects of the application of SM in vivo on SIAs
SM showed different effects on PVBs and VT. SM decreased the occurrence of PVBs caused by stretching. The Ca 2+ cycle and the activities of SACs are the main mechanisms of SIAs (Lab, 1996) . In short, the activities of SACs during stretching caused an increase in intracellular Ca 2+ ([Ca 2+ ] i ), which leads to after-depolarization and subsequent triggered activity (Fu et al., 2007) . The mechanism of the antiarrhythmia effect of SM might be that by blocking SACs, it inhibits the increase in [Ca 2+ ] i .
On the other hand, SM did not alter the occurrence of VT induced by aortic occlusion. There may have been several possible reasons for this: (1) the lack of a significant difference in this study may have been because of the small sample size; (2) absorption efficiency may have varied among different tissues following the application of SM in vivo, causing our results to differ from those of previous studies (Yeung et al., 2005; Spangenburg and McBride, 2006) ; (3) besides SACs, a more complicated mechanism may be involved in stretch-induced VT.
Conclusions
Stretch-induced MAPD 90 changes and arrhythmias via MEF were observed in chronically infarcted myocardium. The use of SM in vivo decreased the incidence rate of PVBs but not VT, suggesting the involvement of SACs in MEF but that there might be other mechanisms involved in the formation of VT in chronically infarcted myocardium.
The results of our study revealed increased MEF in chronic MI and the effectiveness of SM in vivo in minimizing certain electrophysiological changes during stretching. However, because of the risk of hearing and kidney damage caused by SM, further pharmacological studies are needed to find SM analogues which are safe for clinical application. Moreover, other studies will be necessary to explore further the mechanism of action of SIAs because other mechanosensitive ion channels in myocardium (Healy and McCulloch, 2005) may also be involved in stretchinduced electrical activity abnormalities, especially VT. 
